Association Between Severe Hypoglycemia, Adverse Macrovascular Events, and Inflammation in the Edinburgh Type 2 Diabetes Study
The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether a history of severe hypoglycemia was associated with an increased risk of subsequent macrovascular events in people with type 2 diabetes and to explore possible mediation of this association by inflammation. RESEARCH DESIGN AND METHODS: A cohort of 1,066 adults aged 60–75 years with type 2 diabetes was evaluated prospectively. Baseline history of severe hypoglycemia and plasma levels of the inflammatory markers C-reactive protein, fibrinogen, interleukin-6, and tumor necrosis factor-α were recorded. Their association with incident macrovascular events after 4 years was explored. RESULTS: At baseline, 87 participants (8.2%) reported one or more episodes of severe hypoglycemia within the preceding year, and at follow-up 99 participants (9.3%) had suffered a new macrovascular event. Hypoglycemia was associated with increased odds of macrovascular events (odds ratio [OR] 2.11 [95% CI 1.06, 4.21], P = 0.035), including coronary heart events (OR 2.44 [95% CI 1.13, 5.26], P = 0.023), largely due to increased myocardial infarction (OR 4.02 [95% CI 1.54, 10.48], P = 0.004). Hypoglycemia was also associated with increased levels of inflammatory markers, including a general inflammation factor derived using principal-components analysis (P = 0.030, after adjustment for cardiometabolic risk factors). However, the significant association between hypoglycemia and macrovascular events persisted after adjustment for inflammatory markers. CONCLUSIONS: The odds of suffering a macrovascular event were higher in patients with type 2 diabetes who had a history of severe hypoglycemia. There was no evidence that a proinflammatory state had a major role in mediating this association.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [196]
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Microvascular and Macrovascular Complications of Diabetes
Fowler, M. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.2.77 · Cited by 1,954
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Inflammation and cardiovascular disease mechanisms
Libby, P. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.456s · Cited by 1,104 · cited 1×
“Chronic inflammation has been shown to be associated with macrovascular disease as well as insulin resistance and diabetes (16,17).”
BackgroundBonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Diabetes and cognitive dysfunction
McCrimmon, R. J., Ryan, C. M., & Frier, B. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60360-2 · Cited by 880
Self-citationGoto, A., Arah, O. A., Goto, M., Terauchi, Y., & Noda, M. (2013) · BMJ · doi:10.1136/bmj.f4533 · Cited by 492 · cited 2×
“(35), bias analysis was used to determine whether coexisting comorbid illnesses, and not hypoglycemia alone, could account for the increased risk of cardiovascular morbidity.”
BackgroundAssociation of Hypoglycemia and Cardiac Ischemia
Desouza, C., Salazar, H., Cheong, B., Murgo, J., & Fonseca, V. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1485 · Cited by 406 · cited 1×
“It has also been argued that the increased morbidity and mortality associated with hypoglycemia may result from greater blood glucose fluctuations and is not specific to hypoglycemia per se (37,38).”
BackgroundHypoglycemia and cardiovascular risks
Frier, B. M., Schernthaner, G., & Heller, S. R. (2011) · Diabetes Care · doi:10.2337/dc11-s220 · Cited by 381 · cited 2×
“Acute vascular events may be provoked by subsequent hypoglycemia through the profound hemodynamic and electrophysiological changes that occur with sympatho-adrenal activation (3,38).”
BackgroundSelf-citationVascular disease and diabetes: Is hypoglycaemia an aggravating factor?
Wright, R. J., & Frier, B. M. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.865 · Cited by 336 · cited 2×
“Hypoglycemia also induces hemorrheological changes, white cell activation, vasoconstriction, and the release of inflammatory mediators and cytokines (3,4,39).”
BackgroundSelf-citationFeinkohl, I., Aung, P. P., Keller, M., Robertson, C. M., Morling, J. R., McLachlan, S., Deary, I. J., Frier, B. M., Strachan, M. W. J., Price, J. F., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1384 · Cited by 266
Self-citationHsu, P.-F., Sung, S.-H., Cheng, H.-M., Yeh, J.-S., Liu, W.-L., Chan, W.-L., Chen, C.-H., Chou, P., & Chuang, S.-Y. (2013) · Diabetes Care · doi:10.2337/dc12-0916 · Cited by 249
Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
The ORIGIN Trial Investigators, Mellbin, L. G., Rydén, L., Riddle, M. C., Probstfield, J., Rosenstock, J., Díaz, R., Yusuf, S., & Gerstein, H. C. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht332 · Cited by 247
Gogitidze Joy, N., Hedrington, M. S., Briscoe, V. J., Tate, D. B., Ertl, A. C., & Davis, S. N. (2010) · Diabetes Care · doi:10.2337/dc09-0354 · Cited by 239
Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation
Wright, R. J., Newby, D. E., Stirling, D., Ludlam, C. A., Macdonald, I. A., & Frier, B. M. (2010) · Diabetes Care · doi:10.2337/dc10-0013 · Cited by 208
Self-citationMarioni, R. E., Strachan, M. W. J., Reynolds, R. M., Lowe, G. D. O., Mitchell, R. J., Fowkes, F. G. R., Frier, B. M., Lee, A. J., Butcher, I., Rumley, A., et al. (2010) · Diabetes · doi:10.2337/db09-1163 · Cited by 167 · cited 3×
“The presenceofmacrovascular disease (a composite of MI, angina, stroke, and TIA) at baseline was accepted if subjects met predefined criteria based on the results of the questionnaire, a positive WHO history of chest pain, an abnormal ECG result, and hospital discharge data linkage from ISD (23).”
BackgroundInfluentialSelf-citationSchopman, J. E., Geddes, J., & Frier, B. M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.013 · Cited by 150
Self-citationMuggeo, M., Verlato, G., Bonora, E., Zoppini, G., Corbellini, M., & de Marco, R. (1997) · Circulation · doi:10.1161/01.cir.96.6.1750 · Cited by 142 · cited 3×
“In such people, careful consideration shouldbe given towhat targets are appropriate, particularly in those people with a long duration of diabetes and in older people, who are at a greater risk of hypoglycemia (38).”
BackgroundPathophysiology, diagnosis and treatment of endometriosis.
Schindler, A. E. (2004) · PubMed · Cited by 139
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
Hanefeld, M., Dütting, E. D., & Bramlage, P. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-135 · Cited by 104
Aung, P. P., Strachan, M. W. J., Frier, B. M., Butcher, I., Deary, I. J., Price, J. F., & on behalf of the Edinburgh Type 2 Diabetes Study Investigators (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03505.x · Cited by 97
Self-citationZhao, Y., Campbell, C. R., Fonseca, V., & Shi, L. (2012) · Diabetes Care · doi:10.2337/dc11-2048 · Cited by 94
Mellbin, L., Malmberg, K., Waldenström, A. P., Wedel, H., Rydén, L., & for the DIGAMI 2 investigators (2008) · Heart · doi:10.1136/hrt.2008.152835 · Cited by 88
Hypoglycemia: Pathophysiology, Diagnosis, and Treatment
Cryer, P. E. (1997) · Medical Entomology and Zoology · Cited by 86
Hypoglycemia increases serum interleukin-6 levels in healthy men and women
Dotson, S., Freeman, R., Failing, H. J., & Adler, G. K. (2008) · Diabetes Care · doi:10.2337/dc07-2243 · Cited by 70
Cryer, P. E. (1997) · doi:10.1093/oso/9780195113259.001.0001 · Cited by 70
Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., Williamson, R. M., Nee, L. D., McLachlan, S., Sattar, N., Welsh, P., Reynolds, R. M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2241 · Cited by 69
Self-citationThe Edinburgh Type 2 Diabetes Study: study protocol
Price, J. F., Reynolds, R. M., Mitchell, R. J., Williamson, R. M., Fowkes, F. G. R., Deary, I. J., Lee, A. J., Frier, B. M., Hayes, P. C., & Strachan, M. W. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-18 · Cited by 68
Self-citationDOES HYPOGLYCAEMIA AGGRAVATE THE COMPLICATIONS OF DIABETES?
Frier, B. M., & Hilsted, J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92692-3 · Cited by 52
Self-citationAnderssohn, M., McLachlan, S., Lüneburg, N., Robertson, C. M., Schwedhelm, E., Williamson, R. M., Strachan, M. W. J., Ajjan, R., Grant, P. J., Böger, R. H., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0546 · Cited by 29
Self-citationAkram, K., Pedersen‐Bjergaard, U., Carstensen, B., Borch‐Johnsen, K., & Thorsteinsson, B. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02834.x · Cited by 22
Inflammation and its Association with Glucose Disorders and Cardiovascular Disease
Barzilay, J. I., & Freedland, E. S. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302020-00002 · Cited by 22 · cited 1×
“Chronic inflammation has been shown to be associated with macrovascular disease as well as insulin resistance and diabetes (16,17).”
BackgroundBiessels, G. J. (2014) · Diabetic hypoglycaemia · Cited by 6
Cited by
Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Self-citationArnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Hirsch, I. B. (2015) · Diabetes Care · doi:10.2337/dc14-2898 · Cited by 282
“While there are numerous mechanisms by which hypoglycemia may result in poor macrovascular outcomes (13), hypoglycemia is in fact associated with both macrovascular and microvascular end points in type 2 diabetes (14,15),”
BackgroundLee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care · doi:10.2337/dc17-1669 · Cited by 226
Davis, S. N., Duckworth, W. C., Emanuele, N., Hayward, R. A., Wiitala, W. L., Thottapurathu, L., Reda, D. J., & Reaven, P. D. (2018) · Diabetes Care · doi:10.2337/dc18-1144 · Cited by 136
Metadata
- Authors
- Bedenis, R., Price, A. H., Robertson, C. M., Morling, J. R., Frier, B. M., Strachan, M. W. J., & Price, J. F.
- Affiliations
- University of Edinburgh (GB)
- Centre for Population Health Sciences, University of Edinburgh, Edinburgh, Scotland, U.K.
- Edinburgh Royal Infirmary (GB)
- Western General Hospital (GB)
- Corresponding author
- Bedenis, Rachel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-11-08
- Volume
- 37
- Issue
- 12
- Pages
- 3301-3308
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2157363221
- Cited by
- 87
- References
- 43
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 10 · 2022: 6 · 2021: 15 · 2020: 11 · 2019: 7 · 2018: 5 · 2017: 9 · 2016: 12 · 2015: 3
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, macrovascular events, myocardial infarction, coronary artery disease, inflammation, C-reactive protein, fibrinogen, interleukin-6, TNF-α, older adults
- MeSH terms
- Adult, Aged, C-Reactive Protein, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, United Kingdom, Humans, Hypoglycemia, Inflammation, Male, Middle Aged, Risk Factors, Tumor Necrosis Factor-alpha, Interleukin-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.